NMDA Spiro-Lactam and BIS-Spiro-Lactam Receiver Modulators and Their Application

摘要

It refers to a compound represented by Formula I or Formula II; or a pharmacologically acceptable salt, a stereoisomer and/or a positive oxidant, characterized by the fact that R1 and R2 are selected independently of H, C1-C6 and other substances; and R3 is selected from H, C1-C6 tars. In addition, R4, R5, R6 and R7 are independent of H, halogen, hydroxyl, etc. as well as a pharmacological formulation or synthesis, including the invention of a compound (possibly its various racemic or stereoisomerization mixtures) and a pharmacist who accepts B in pre-pharmacology. The forum where you want to post is a He also mentioned methods of preparation and treatment.For this purpose, a combination therapy of one or more other active agents can also be used. Current inventions help to treat depression and related diseases by regulating the activity of N-met-D-Asparato (NMDA) receivers.